Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors
Risks
Default risk
Data is available to registered users only
Volatility
Data is available to registered users only
Selling difficulty
Data is available to registered users only
Stress test
Data is available to registered users only
Country risks
Data is available to registered users only
Other risks
Data is available to registered users only
Sign up to access detailed risk analysis
About
With its origins as KetamineOne Capital Limited, this innovative wellness organization is dedicated to advancing ketamine-assisted therapy and psychedelic medicines. It achieves this mission by managing a network of healthcare clinics across North America. The company, which commenced operations in 2017 and is headquartered in Vancouver, Canada, was formerly recognized as Myconic Capital Corp. Its transition to the KetamineOne Capital Limited name occurred in June 2021.